↓ Skip to main content

Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance

Overview of attention for article published in BMC Infectious Diseases, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance
Published in
BMC Infectious Diseases, April 2022
DOI 10.1186/s12879-022-07329-y
Pubmed ID
Authors

Mirae Park, Ajit Lalvani, Giovanni Satta, Onn Min Kon

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 11%
Other 3 8%
Student > Master 3 8%
Researcher 3 8%
Student > Doctoral Student 2 5%
Other 3 8%
Unknown 19 51%
Readers by discipline Count As %
Medicine and Dentistry 9 24%
Immunology and Microbiology 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Agricultural and Biological Sciences 2 5%
Computer Science 1 3%
Other 3 8%
Unknown 17 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2022.
All research outputs
#13,795,127
of 23,767,404 outputs
Outputs from BMC Infectious Diseases
#3,292
of 7,933 outputs
Outputs of similar age
#185,860
of 445,540 outputs
Outputs of similar age from BMC Infectious Diseases
#85
of 236 outputs
Altmetric has tracked 23,767,404 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,933 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,540 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.